Nuvation Bio Inc
(NUVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -168,035 | -112,243 | -53,236 | -567,939 | -518,494 |
| Depreciation Amortization | 1,535 | 684 | 310 | 683 | 464 |
| Accounts receivable | 4,399 | 10,029 | 12,313 | -12,722 | -112 |
| Accounts payable and accrued liabilities | 9,012 | 16,071 | 4,189 | -1,654 | 4,378 |
| Other Working Capital | -5,704 | 2,953 | 2,759 | -12,507 | -5,761 |
| Other Operating Activity | 15,099 | -8,299 | -8,962 | 463,726 | 435,414 |
| Operating Cash Flow | $-143,694 | $-90,805 | $-42,627 | $-130,413 | $-84,111 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,702 | 109,311 | 54,254 | 110,437 | 58,586 |
| PPE Investments | -265 | -253 | -72 | -162 | -175 |
| Net Acquisitions | N/A | N/A | N/A | 19,862 | 19,863 |
| Purchase Sale Intangibles | -8,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -8,000 | 0 | 0 | -7,434 | -7,343 |
| Investing Cash Flow | $12,437 | $109,058 | $54,182 | $122,703 | $70,931 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 48,901 | 48,901 | N/A | 12,609 | 7,035 |
| Debt Repayment | -700 | -700 | -534 | -17,163 | -9,530 |
| Common Stock Issued | 2,935 | 2,377 | 1,082 | 4,885 | 3,726 |
| Other Financing Activity | 143,336 | 143,393 | 0 | 0 | 0 |
| Financing Cash Flow | $194,472 | $193,971 | $548 | $331 | $1,231 |
| Exchange Rate Effect | -41 | 23 | 151 | 453 | -664 |
| Beginning Cash Position | 35,723 | 35,723 | 35,723 | 42,649 | 42,649 |
| End Cash Position | 98,897 | 247,970 | 47,977 | 35,723 | 30,036 |
| Net Cash Flow | $63,174 | $212,247 | $12,254 | $-6,926 | $-12,613 |
| Free Cash Flow | |||||
| Operating Cash Flow | -143,694 | -90,805 | -42,627 | -130,413 | -84,111 |
| Capital Expenditure | -265 | -253 | -72 | -162 | -175 |
| Free Cash Flow | -143,959 | -91,058 | -42,699 | -130,575 | -84,286 |